Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

NCT02743897 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease

Interventions

DRUG: Zepatier
DRUG: Mavyret

Sponsor

University of Pennsylvania

Collaborators

[object Object]